Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR3 | P46089 | 1/20 | 0.54 |
| ▸ | MEN1 | O00255 | 2/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.42 |
| ▸ | ESR1 | P03372 | 1/20 | 0.40 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.40 |
| ▸ | P2RX7 | Q99572 | 1/20 | 0.39 |
| ▸ | APAF1 | O14727 | 1/20 | 0.38 |
| ▸ | TDP2 | O95551 | 1/20 | 0.38 |
| ▸ | CHEK1 | O14757 | 2/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.37 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10216422 | 0.75 | GPR3 (0.54) | GPR3MEN1KMT2AESR1ESR2 | |
| SCHEMBL7467947 | 0.72 | GPR3 (0.50) | GPR3MEN1KMT2AESR1ESR2 | |
| SCHEMBL29481 | 0.71 | GPR3 (1.00) | GPR3MEN1KMT2ACHEK1L3MBTL1 | |
| SCHEMBL29387122 | 0.71 | GPR3 (1.00) | GPR3MEN1KMT2ACHEK1L3MBTL1 | |
| SCHEMBL11796916 | 0.68 | MEN1 (0.47) | GPR3MEN1KMT2AHSD11B1 | |
| SCHEMBL11800594 | 0.68 | GPR3 (0.45) | GPR3MEN1KMT2ACHEK1HSD11B1 | |
| SCHEMBL7473284 | 0.67 | GPR3 (0.44) | GPR3MEN1KMT2AESR1ESR2 | |
| SCHEMBL7473289 | 0.67 | GPR3 (0.44) | GPR3MEN1KMT2AESR1ESR2 | |
| SCHEMBL17343657 | 0.67 | GPR3 (0.54) | GPR3MEN1KMT2A | |
| SCHEMBL31472931 | 0.66 | GPR3 (0.75) | GPR3MEN1KMT2AESR1ESR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200354576-A1 | DYEING COMPOSITION, DYED PRODUCT, AND AZO COLORING AGENT | FUJIFILM CORPORATION (JP) | 2020-11-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200354576-A1 | DYEING COMPOSITION, DYED PRODUCT, AND AZO COLORING AGENT | CYP1B1, CYP1A1, NAT1 | GPR3 3442/4885MEN1 20/4885KMT2A 1097/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.